4
Changes in Ownership
Nuvectis Pharma, Inc. Filed Acc 0001104659-22-060910
Director bought 3,000 shares at an average $16.88 ($50,633)
From the SEC's structured data for this filing
Trades in this filing
Kaplan Matthew L. · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-05-12 | Purchase : show line 1 in the form | +1,177 | $15.96 | $18,785 | 33,937 | D |
| 2022-05-12 | Purchase : show line 2 in the form | +1,823 | $17.47 | $31,848 | 35,760 | D |
| Open-market purchases · 3,000 sh · avg $16.88 · $50,633 | ||||||
Loading xslF345X03/tm2215423d2_4.xml…